Bain Capital Life Sciences Opportunities III, LP
Related Filers (8)
- Kyverna Therapeutics, Inc. (3)
- Cara Therapeutics, Inc. (2)
- Disc Medicine, Inc. (2)
- Cabaletta Bio, Inc. (2)
- Bain Capital Life Sciences Investors, LLC (2)
- Bain Capital Life Sciences Fund III, L.P. (2)
- Bain Capital Life Sciences Opportunities III GP, LLC (2)
- Bain Capital Life Sciences III General Partner, LLC (2)
- Show More ...
Other (5)
13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (9)
SC 13G
Wednesday, 2/14/2024
Kyverna Therapeutics, Inc.: Major Shareholders
4
Wednesday, 2/14/2024
Kyverna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/13/2024
Cara Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Disc Medicine, Inc.: Major Shareholders
3
Wednesday, 2/7/2024
Kyverna Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 6/1/2023
Cabaletta Bio, Inc.: Major Shareholders
SC 13G
Friday, 2/24/2023
Disc Medicine, Inc.: Major Shareholders
SC 13G
Friday, 11/18/2022
Cara Therapeutics, Inc.: Major Shareholders